Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat

American Journal of Hypertension

Volumn 10, Issue 9 I, 1997, Pages 1058-1063

  Valentin, J P ^a   Jover, B ^a   Maffre, M ^a   Bertolino, F ^a   Bessac, A M ^a   John, G W ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Albumin extravasation; Angiotensin II receptor subtypes; Hematocrit; Losartan; Plasma exudation; SQ 29,548; Thromboxane A2; Thromboxane prostanoid receptor antagonist

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; PROSTANOID RECEPTOR; THROMBOXANE A2 RECEPTOR;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD VESSEL PERMEABILITY; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAPILLARY PERMEABILITY; ENALAPRIL; HEMATOCRIT; HYDRAZINES; LOSARTAN; MALE; MICROCIRCULATION; PLASMA VOLUME; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, THROMBOXANE; SERUM ALBUMIN; VASOCONSTRICTOR AGENTS;

EID: 0030776797     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00276-8     Document Type: Article

References (16)